View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 11, 2011

MagForce treats glioblastoma with NanoTherm therapy

MagForce, a medical technology company focused on nanomedicine in oncology, has announced that it has treated a recurrent glioblastoma patient using NanoTherm therapy.

MagForce, a medical technology company focused on nanomedicine in oncology, has announced that it has treated a recurrent glioblastoma patient using NanoTherm therapy.

The therapy involves the direct injection of magnetic nanoparticles into the tumour, and their subsequent heating by an alternating magnetic field.

The therapy was carried out at the University of Giessen and Charité University Medical Center Berlin.

Based on an individual patient agreement, the treatment costs are being covered by a German state insurance company.

MagForce CEO Peter Heinrich said that, through its collaborations with experts in both and internationally, the company plans to further develop this treatment approach for a variety of solid tumour indications with high medical need.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management